Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, placebo-controlled, 16-week study designed to explore the safety
and efficacy of IMC-1 for the treatment of patients with fibromyalgia.